Is the Combination of Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios a Useful Predictor of Treatment Response and Prognosis in Patients with Non-Small Cell Lung Cancer?

(2014). Is the Combination of Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios a Useful Predictor of Treatment Response and Prognosis in Patients with Non-Small Cell Lung Cancer?. Asian Pacific Journal of Cancer Prevention, 15(10), 4373-4373.

. "Is the Combination of Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios a Useful Predictor of Treatment Response and Prognosis in Patients with Non-Small Cell Lung Cancer?", Asian Pacific Journal of Cancer Prevention, 15, 10, 2014, 4373-4373.

(2014). 'Is the Combination of Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios a Useful Predictor of Treatment Response and Prognosis in Patients with Non-Small Cell Lung Cancer?', Asian Pacific Journal of Cancer Prevention, 15(10), pp. 4373-4373.

, "Is the Combination of Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios a Useful Predictor of Treatment Response and Prognosis in Patients with Non-Small Cell Lung Cancer?," Asian Pacific Journal of Cancer Prevention, 15 10 (2014): 4373-4373,

Is the Combination of Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios a Useful Predictor of Treatment Response and Prognosis in Patients with Non-Small Cell Lung Cancer?. Asian Pacific Journal of Cancer Prevention, 2014; 15(10): 4373-4373.